These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19055640)

  • 21. Prothrombin time and partial thromboplastin time assay considerations.
    Ng VL
    Clin Lab Med; 2009 Jun; 29(2):253-63. PubMed ID: 19665677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance evaluation of the CoaguChek S system.
    Plesch W; Klimpel P
    Haematologica; 2002 May; 87(5):557-9. PubMed ID: 12010676
    [No Abstract]   [Full Text] [Related]  

  • 23. External quality assessment of CoaguChek point-of-care testing prothrombin time/international ratio monitors.
    Kitchen S; Kitchen D; Jennings I; Woods T; Walker I
    Am J Clin Pathol; 2008 May; 129(5):825-6. PubMed ID: 18481407
    [No Abstract]   [Full Text] [Related]  

  • 24. Coagulation abnormalities in patients who have liver disease.
    Trotter JF
    Clin Liver Dis; 2006 Aug; 10(3):665-78, x-xi. PubMed ID: 17162234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparability of the results of PT-INR with local MNPT and APTTR with MNAPTT on different coagulation analyzers in China.
    Peng L; Yan C; Wu X; Nie L
    Int J Lab Hematol; 2009 Jun; 31(3):352-8. PubMed ID: 18510575
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Assessment of thromboplastins according to the WHO guidelines and the results of external quality control].
    Berkovskiĭ AL; Sergeeva EV; Kachalova ND; Gurvits ID; Suvorov AV; Ul'ianova IS; Ivanov IuG; Kozlov AA
    Klin Lab Diagn; 2011 Apr; (4):30-3. PubMed ID: 21735677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
    Wieloch M; Hillarp A; Strandberg K; Nilsson C; Svensson PJ
    Thromb Res; 2009 Jul; 124(3):344-8. PubMed ID: 19423152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. International collaborative study for the calibration of a proposed international standard for thromboplastin, rabbit, plain.
    Chantarangkul V; van den Besselaar AM; Witteveen E; Tripodi A
    J Thromb Haemost; 2006 Jun; 4(6):1339-45. PubMed ID: 16706980
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving MELD for use in acute liver failure.
    McPhail MJ
    J Hepatol; 2011 Jun; 54(6):1320; author reply 1320-1. PubMed ID: 21145930
    [No Abstract]   [Full Text] [Related]  

  • 30. Liver disease, coagulation testing, and hemostasis.
    Ng VL
    Clin Lab Med; 2009 Jun; 29(2):265-82. PubMed ID: 19665678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Can acute renal insufficiency increase the effect of warfarin?].
    Arnason B; Matthisson J; Madsen H
    Ugeskr Laeger; 2009 Mar; 171(12):1012. PubMed ID: 19284926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fresh-frozen plasma transfusion in patients with mild coagulation abnormalities at a large Canadian transfusion center.
    Devine DV
    Transfusion; 2007 Apr; 47(4):749. PubMed ID: 17381637
    [No Abstract]   [Full Text] [Related]  

  • 33. Fresh-frozen plasma transfusion in patients with mild coagulation abnormalities at a large Canadian transfusion center.
    Cheng CK; Sadek I
    Transfusion; 2007 Apr; 47(4):748; author reply 749. PubMed ID: 17381635
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute liver failure: what is it?
    Wlodzimirow KA; Eslami S; Abu-Hanna A; Nieuwoudt M; Chamuleau RA
    Hepatology; 2012 Apr; 55(4):1306-7. PubMed ID: 22161273
    [No Abstract]   [Full Text] [Related]  

  • 35. An oral vitamin K protocol to reverse over-anticoagulation in patients presenting with an International Normalised Ratio above 10.0.
    Denas G; Cucchini U; Iliceto S; Pengo V
    Thromb Haemost; 2009 Feb; 101(2):410-1. PubMed ID: 19190831
    [No Abstract]   [Full Text] [Related]  

  • 36. CoaguChek point-of-care testing prothrombin time monitors.
    Braun SL
    Am J Clin Pathol; 2007 Oct; 128(4):671-2; author reply 672. PubMed ID: 17924500
    [No Abstract]   [Full Text] [Related]  

  • 37. A comprehensive model for the humoral coagulation network in humans.
    Wajima T; Isbister GK; Duffull SB
    Clin Pharmacol Ther; 2009 Sep; 86(3):290-8. PubMed ID: 19516255
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Massive, fatal, intracardiac thrombosis associated with prothrombin complex concentrate.
    Warren O; Simon B
    Ann Emerg Med; 2009 Jun; 53(6):758-61. PubMed ID: 19181420
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Warfarin does not interfere with lupus anticoagulant detection by dilute Russell's viper venom time.
    Olteanu H; Downes KA; Patel J; Praprotnik D; Sarode R
    Clin Lab; 2009; 55(3-4):138-42. PubMed ID: 19462936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
    Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
    Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.